An analysis in the prevalence and influencing factors of COPD among people aged 40 years and above in Guizhou Province
-
摘要:
目的 分析研究贵州省40岁及以上不同性别人群慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)流行状况及其影响因素,为COPD预防提供依据。 方法 采用多阶段分层整群抽样方法,抽取贵州省COPD监测地区2 599名40岁及以上常住居民,进行问卷调查、体格及肺功能检查。 结果 贵州省监测地区COPD患病率为10.7%,男性患病率(13.0%)高于女性(7.6%)(χ2=16.951, P<0.001)。Logistic回归分析模型分析结果显示,在男性人群中,年龄、吸烟、肺结核、慢性支气管炎病史与COPD患病密切相关;而女性人群中,年龄、脑血管、肺气肿病史、慢性支气管炎病史、鼻炎与COPD患病密切相关。 结论 贵州省监测地区COPD患病率及影响因素存在性别差异,为降低COPD患病率,男性以控烟和采取呼吸系统疾病筛查为主要措施,女性重点加强呼吸系统疾病筛查。 Abstract:Objective To explore the gender comparison in prevalence and influencing factors of chronic obstructive pulmonary disease (COPD) among people aged 40 years and above in Guizhou Province, to provide basis for risk stratification and prevention of COPD. Methods A total of 2 599 residents aged 40 years and over in the COPD monitored area of Guizhou Province was selected according to a multi-stage stratified cluster sampling method. And all participants were underwent a questionnaire survey, physical examination, and lung function test. Results The total prevalence of COPD in the monitored area of Guizhou Province was 10.7%. The prevalence of male (13.0%) was higher than that of female (7.6%) (χ2=16.951, P < 0.001). Unconditional multivariate Logistic regression analysis suggested that age, smokers, tuberculosis, and history of chronic bronchitis were significantly associated with COPD in male population; While age, cerebrovascular diseases, history of emphysema, history of chronic bronchitis, and rhinitis were significantly associated with COPD in the female. Conclusions The prevalence and influencing factors of COPD were different between male and female. In order to reduce the incidence of COPD, smoking control and respiratory disease screening are main measures for men, and respiratory disease screening is the main measure for women. -
表 1 贵州省监测地区40岁及以上COPD调查人口基本情况
Table 1. Basic characteristics of COPD investigation population aged 40 years old and above in Guizhou monitoring area
变量 总人群 男性 女性 χ2值 P值 人数 构成比(%) 人数 构成比(%) 人数 构成比(%) 年龄组(岁) 13.702 0.003 40~ < 50 1 041 40.05 622 42.75 419 36.62 50~ < 60 796 30.63 444 30.51 352 30.77 60~ < 70 583 22.43 300 20.62 283 24.74 ≥70 179 6.89 89 6.12 90 7.87 民族 1.574 0.215 汉族 2 146 82.57 1 189 81.72 957 83.65 少数民族 453 17.43 266 18.28 187 16.35 文化程度a 33.495 0.001 低水平 2 356 90.69 1276 87.76 1 080 94.41 高水平 242 9.31 178 12.24 64 5.59 婚姻a 12.205 0.001 无配偶(未婚、分居、离异丧偶) 318 12.24 149 10.25 169 14.77 有配偶(已婚、同居) 2 280 87.76 1 305 89.75 975 85.23 吸烟情况a 1705.917 0.001 不吸烟 1 257 48.46 182 12.53 1 075 94.13 戒烟 190 7.32 172 11.85 18 1.58 吸烟 1 147 44.22 1 098 75.62 49 4.29 BMI等级a 19.995 0.001 体重过低 60 2.34 37 2.58 23 2.04 正常 1 308 51.07 786 54.73 522 46.40 超重 719 28.08 369 25.70 350 31.11 肥胖 474 18.51 244 16.99 230 20.45 COPD患病情况a 16.951 0.001 未患病 2 013 89.27 1 127 86.96 886 92.39 患病 242 10.73 169 13.04 73 7.61 母亲怀孕时是否吸烟a 4.389 0.111 否 1 971 91.59 1 081 91.15 890 92.13 是 181 8.41 105 8.85 76 7.87 14岁以前因患肺炎或支气管炎而住院a 4.499 0.105 否 2 322 97.77 1 283 97.49 1 039 98.11 是 53 2.23 33 2.51 20 1.89 家庭使用取暖污染燃料a 0.126 0.722 否 2 152 82.83 1 201 82.60 951 83.13 是 446 17.17 253 17.40 193 16.87 14岁前曾与每天吸烟者共同生活a 50.219 0.001 否 1 353 54.76 668 48.44 685 62.73 是 1 118 45.24 711 51.56 407 37.27 经常接触做饭油烟a 289.591 0.001 否 1 163 44.77 865 59.49 298 26.05 是 1 435 55.23 589 40.51 846 73.95 冬季最主要取暖形式及燃料a 7.914 0.161 不取暖 24 0.92 19 1.31 5 0.44 集中供暖 22 0.85 14 0.96 8 0.70 电(电暖器/电热风/空调) 399 15.36 219 15.06 180 15.74 煤/煤球/煤饼/炭 2 002 77.06 1 111 76.41 891 77.88 木头/柴草/农作物秸秆 150 5.77 90 6.19 60 5.24 其他 1 0.04 1 0.07 0 0 注:a有数据缺失。 表 2 贵州省监测地区不同性别COPD危险因素的单因素分析结果[n(%)]
Table 2. Univariate analysis for the risk factors of COPD in different genders of Guizhou monitoring areas [n(%)]
变量 总人群a 男 女 患病人数(%) χ2值 P值 患病人数(%) χ2值 P值 患病人数(%) χ2值 P值 性别 16.951 <0.001 男 169(13.0) 女 73(7.6) 年龄分组(岁) 95.998 <0.001 65.103 <0.001 41.84 <0.001 40~ < 50 45(4.8) 34(6.0) 11(3.0) 50~ < 60 74(10.6) 51(13.1) 23(7.4) 60~ < 70 88(18.0) 63(23.9) 25(11.1) ≥70 35(26.7) 21(26.9) 14(26.4) 民族 1.618 0.203 3.171 0.075 0.038 0.845 汉族 208(11.1) 147(13.8) 61(7.5) 少数民族 34(8.9) 22(9.5) 12(8.0) 文化程度 3.428 0.064 1.874 0.171 5.274 0.022 低水平 226(11.1) 153(13.5) 73(8.1) 高水平 16(7.1) 16(9.7) 0(0.0) 婚姻 1.432 0.231 2.143 0.143 0.331 0.565 无配偶 34(12.9) 22(17.2) 12(8.8) 有配偶 208(10.5) 147(12.6) 61(7.4) BMI等级 15.025 0.002 16.313 <0.001 8.103 0.044 过低 9(22.5) 6(23.1) 3(21.4) 正常 137(12.0) 111(15.7) 26(5.9) 超重 67(10.5) 37(10.9) 30(10.0) 肥胖 29(6.7) 15(6.7) 14(6.8) 吸烟情况 26.117 <0.001 7.627 0.022 2.473 0.292 不吸烟 78(7.3) 11(6.7) 67(7.4) 戒烟 27(16.5) 24(16.3) 3(17.6) 吸烟 137(13.4) 134(13.7) 3(7.3) 14岁前曾与每天吸烟者共同生活 3.291 0.071 1.202 0.273 0.454 0.501 否 107(9.3) 69(11.6) 38(6.7) 是 115(11.7) 87(13.7) 28(7.9) 家庭取暖使用污染燃料 13.401 <0.001 8.332 0.004 5.498 0.019 否 21(5.5) 16(7.1) 5(3.1) 是 221(11.8) 153(14.3) 68(8.5) 经常接触做饭油烟 0.006 0.943 2.426 0.121 0.176 0.675 否 108(10.7) 91(11.8) 17(7.0) 是 134(10.8) 78(14.8) 56(7.8) 冬季最主要取暖形式及燃料 16.209 0.003 11.805 0.019 9.612 0.048 不取暖 2(10.0) 1(5.9) 1(33.3) 集中供暖 3(14.3) 3(23.1) 0(0.0) 电 16(4.7) 12(6.2) 4(2.7) 煤/煤球/煤饼/炭 204(11.7) 141(14.1) 63(8.4) 木头/柴草/农作物秸秆 17(13.6) 12(16.7) 5(9.4) 肺间质纤维化 16.643 <0.001 13.346 <0.001 6.148 0.130 否 240(10.7) 167(12.9) 73(7.6) 是 2(100.0) 2(100.0) 0(0.0) 14岁以前因患肺炎或支气管炎而住院 2.430 0.297 0.586 0.746 2.614 0.271 否 211(10.5) 148(12.9) 63(7.2) 是 8(17.0) 5(17.9) 3(15.8) 支气管扩张症 21.104 <0.001 13.456 <0.001 5.681 0.070 否 233(10.4) 162(12.7) 71(7.5) 是 9(40.9) 7(43.8) 2(33.3) 骨质疏松 2.731 0.098 0.113 0.737 6.222 0.013 否 226(10.5) 161(13.0) 65(7.1) 是 16(15.7) 8(14.5) 8(17.0) 抑郁症 3.205 0.073 0.214 0.644 12.152 0.076 否 240(10.7) 168(13.0) 72(7.5) 是 2(33.3) 1(20.0) 1(100.0) 脑血管病 2.440 0.118 1.337 0.248 19.151 <0.001 否 232(10.6) 167(13.2) 65(7.0) 是 10(16.9) 2(6.3) 8(29.6) 冠心病 3.545 0.064 0.282 0.595 6.687 0.025 否 233(10.6) 165(13.0) 68(7.3) 是 9(19.1) 4(16.7) 5(21.7) 慢性肺源性心脏病 1.244 0.265 0.214 0.644 1.727 0.272 否 240(10.7) 168(12.97) 72(7.5) 是 2(22.2) 1(20.0) 1(25.0) 肺结核 8.069 0.008 7.595 0.006 0.234 0.629 否 229(10.4) 158(12.6) 71(7.6) 是 13(22.0) 11(27.5) 2(10.5) 肺气肿病史 39.685 <0.001 14.036 <0.001 33.049 <0.001 否 226(10.2) 160(12.6) 66(7.0) 是 16(42.1) 9(39.1) 7(46.7) 慢性支气管炎病史 71.123 <0.001 28.378 <0.001 49.171 <0.001 否 178(8.8) 128(11.2) 50(5.7) 是 64(26.7) 41(26.6) 23(26.7) 哮喘 37.865 <0.001 16.224 <0.001 26.135 <0.001 否 221(10.1) 157(12.4) 64(6.9) 是 21(35.0) 12(36.4) 9(33.3) 鼻炎 6.501 0.011 2.661 0.103 5.121 0.034 否 225(10.4) 159(12.8) 66(7.2) 是 17(18.9) 10(20.8) 7(16.7) 注:a 344人因未完成肺功能检测而未纳入。 表 3 贵州省监测地区不同性别COPD危险因素的多因素分析结果
Table 3. Multivariate analysis for the risk factors of COPD in different genders of Guizhou monitoring areas
变量 β值 Wald值 OR(95% CI)值 P值 变量 β值 Wald值 OR(95% CI)值 P值 总体 男 年龄分层(岁) 年龄分层(岁) 40~<50 1.00 60~<70 1.534 43.360 4.63(2.93~7.32) <0.001 50~ < 60 0.811 16.294 2.23(1.51~3.29) <0.001 ≥70 1.812 31.550 6.12(3.25~11.5) <0.001 60~ < 70 1.369 50.125 4.05(2.75~5.97) <0.001 不吸烟 1.00 ≥70 1.911 53.954 6.68(4.02~11.0) <0.001 戒烟 0.878 6.821 2.15(0.98~4.71) 0.054 不吸烟 1.00 吸烟 0.728 3.312 2.14(1.10~4.17) 0.024 戒烟 0.758 23.507 2.13(1.57~2.89) <0.001 肺结核 1.064 7.502 2.89(1.35~6.20) 0.006 吸烟 0.627 5.988 1.87(1.13~3.09) 0.014 慢性支气管炎病史 0.824 14.058 2.27(1.48~3.50) <0.001 家庭取暖使用污染燃料 0.504 4.277 1.65(1.02~2.66) 0.039 女 肺间质纤维化 0.006 8.610 1.00(1.00~1.01) 0.003 年龄分层(岁) 肺结核 0.753 4.642 2.12(1.07~4.21) 0.031 40~ < 50 1.00 肺气肿病史 0.879 5.256 2.40(1.13~5.10) 0.022 50~ < 60 0.786 4.142 2.19(1.02~4.67) 0.042 慢性支气管炎病史 0.958 26.404 2.60(1.80~3.75) <0.001 60~ < 70 1.191 9.536 3.29(1.54~7.01) 0.002 鼻炎 0.623 4.280 1.86(1.03~3.36) 0.039 ≥70 2.310 25.099 10.0(4.08~24.80) <0.001 男 脑血管病 0.988 4.009 2.68(1.02~7.06) 0.045 年龄分层(岁) 肺气肿病史 1.626 7.344 5.08(1.56~16.40) 0.007 40~ < 50 1.00 慢性支气管炎病史 1.304 15.821 3.68(1.93~7.00) <0.001 50~ < 60 0.820 12.011 2.27(1.42~3.60) <0.001 鼻炎 0.993 4.311 2.69(1.05~6.88) 0.038 -
[1] World Health Organization. The top 10 causes of death[EB/OL]. (2016-12-29)[2021-07-04]. http://www.Who.Int/mediacentre/factsheets/fs310/en/. [2] 中国疾病预防控制中心慢性非传染性疾病预防控制中心, 国家卫生和计划生育委员会统计信息中心. 中国死因监测数据集(2016)[M]. 北京: 中国科学技术出版社, 2017.National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Statistical Information Center of National Health and Family Planning Commission. Data sets of mortality surveillance in China (2016)[M]. Beijing: China Science and Technology Press, 2017. [3] Wang C, Xu JY, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health[CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717. DOI: 10.1016/S0140-6736(18)30841-9. [4] Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study[J]. Lancet, 2005, 366(9500): 1875-1881. DOI: 10.1016/S0140-6736(05)67632-5. [5] Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey[J]. Am J Respir Crit Care Med, 2007, 176(8): 753-760. DOI: 10.1164/rccm.200612.17490C. [6] 中国疾病预防控制中心. 中国居民慢性阻塞性肺疾病监测(2014)工作手册[Z]. 2014, 1-143.Chinese Center for Disease Control and Prevention. Workbook for the National COPD Surveillance in China (2014)[Z]. 2014, 1-143. [7] 包鹤龄, 方利文, 王临虹. 1990-2014年中国40岁及以上人群慢性阻塞性肺疾病患病率Meta分析[J]. 中华流行病学杂志, 2016, 37(1): 119-124. DOI: 10.3760/cma.j.issn.0254-6450.2016.01.026.Bao HL, Fang LW, Wang LH. Prevalence of chronic obstructive pulmonary disease among community population aged ≥40 in China: a Meta-analysis on studies published between 1990 and 2014[J]. Chin J Epidemiol, 2016, 37(1): 119-124. DOI: 10.3760/cma.j.issn.0254-6450.2016.01.026. [8] 张骥, 李东升, 许莹莹. 湖南省长沙市18岁以上居民慢性阻塞性肺疾病流行现状及其影响因素[J]. 职业与健康, 2019, 35(6): 806-809. DOI:10.13329/j.cnki.zyyjk.2019. 0217.Zhang J, Li DS, Xu YY. Prevalence and influencing factors of chronic obstructive pulmonary disease among residents over 18 years old in Changsha City of Hunan Province[J]. Occup Heal, 2019, 35(6): 806-809. DOI:10.13329/j.cnki.zyyjk.2019. 0217. [9] 汪静, 汪仕文, 侯义强. 慢性阻塞性肺疾病发病的影响因素分析[J]. 当代医学, 2015, 21(34): 161-162. DOI:10.3969j.issn.1009-4393.2015.34.106.Wang J, Wang SW, Hou YQ. Analysis of influencing factors of COPD[J]. Contemporary Medicine, 2015, 21(34): 161-162. DOI: 10.3969j.issn.1009-4393.2015.34.106. [10] 张福娟. 青岛市农村居民慢性阻塞性肺病现状调查及危险因素分析[J]. 中国慢性病预防与控制, 2014, 22(4): 464-466. DOI: 10.16386/j.cjpccd.issn.1004-6194.2014.04.025.Zhang FJ. Epidemic and risk factors analysis of COPD in rural residents of Qingdao[J]. Chin J Prev Contr Chron Dis, 2014, 22(4): 464-466. DOI: 10.16386/j.cjpccd.issn.1004-6194.2014.04.025. [11] 张驰, 李俊杰. 某结核病医院肺结核患者患病相关性分析[J]. 心理月刊, 2019, 14(24): 233. DOI: 10.19738/j.cnki.psy.2019.24.213.Zhang C, Li JJ. Correlation analysis of tuberculosis patients in a tuberculosis hospital[J]. PSY, 2019, 14(24): 233. DOI: 10.19738/j.cnki.psy.2019.24.213. [12] 王冰, 苗青. 慢性阻塞性肺疾病性别差异的研究进展[J]. 中华临床医师杂志(电子版), 2013, 7(12): 5564-5567. DOI: 10.3877/cma.j.issn.1674-0785.2013.12.135.Wang B, Miao Q. Research progress on gender differences in COPD[J]. Chin J Clincians (Electronic Edition), 2013, 7(12): 5564-5567. DOI: 10.3877/cma.j.issn.1674-0785.2013.12.135. [13] Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences[J]. Curr Opin Pulm Med, 2004, 10(2): 98-103. DOI: 10.1097/00063198-200403000-00003. [14] 贾双双, 张伟. 从"久病入络"论慢性阻塞性肺疾病合并肺间质纤维化演变[J]. 辽宁中医药大学学报, 2018, 20(9): 95-97. DOI: 10.13194/j.issn.1673-842x.2018.09.026.Jia SS, Zhang W. Discussion on the evolution of chronic obstructive pulmonary disease complicated with pulmonary interstitial fibrosis from "chronic illness into the network"[J]. Journal of Liaoning University of TCM, 2018, 20(9): 95-97. DOI: 10.13194/j.issn.1673-842x.2018.09.026. [15] 苏萌. 慢性阻塞性肺疾病稳定期患者体重指数与肺功能的相关性[D]. 芜湖: 皖南医学院, 2013.Su M. The ralationgship between the body mass index of chronic obstructive pulmonary function[D]. Wuhu: Wannan Medical College, 2013. [16] Wang B, Li L, Yao LC. Detection of p53 gene mutations in sputum samples and their implications in the early diagnosis of lung cancer in suspicious patients[J]. Chin Med J (Engl), 2001, 114(7): 694-697. https://www.ncbi.nlm.nih.gov/pubmed/11780329 [17] 李倩. 慢性阻塞性肺疾病与脑血管疾病相关性研究进展[D]. 重庆: 重庆医科大学, 2017.Li Q. Advances in the correlation of chronic obstructive pulmonary disease and cerebrovascular disease[D]. Chongqing: ChongQing Medical University, 2017. [18] Gulsvik AK, Gulsvik A, Skovlund E, et al. The association between lung function and fatal stroke in a community followed for 4 decades[J]. J Epidemiol Community Health, 2012, 66(11): 1030-1036. DOI: 10.1136/jech-2011-200312. [19] Cote CG, Chapman KR. Diagnosis and treatment considerations for women with COPD[J]. Int J Clin Pract, 2009, 63(3): 486-493. DOI: 10.1111/j.1742-1241.2008.01987.x. [20] Rodríguez-González Moro JM, Izquierdo JL, Antón E, et al. Health-related quality of life in outpatient women with COPD in daily practice: the MUVICE Spanish stu dy[J]. Respir Med, 2009, 103(9): 1303-1312. DOI: 10.1016/j.rmed.2009.04.00. -